Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6860 (MIR6860) is a short (typically 20-24 nucleotide) non-coding RNA gene in humans, formally annotated as "MicroRNA 6860". Like other microRNAs, MIR6860 is presumed to be involved in the regulation of gene expression at the post-transcriptional level by binding to target messenger RNAs (mRNAs) and resulting in their translational inhibition or destabilization. The gene is recorded in standard public gene databases (e.g., GeneCards, HGNC ID: 50086, NCBI Gene ID: 102465518, Ensembl: ENSG00000283326), but as of now, there are no detailed functional studies, known disease links, or evidence for consideration as a therapeutic target. Its mature sequence, targets, physiological roles, and disease associations remain to be characterized. Key Context and Missing Information: - Canonical existence: It is a formally annotated, predicted human microRNA gene. - Functional/clinical evidence: There is currently a lack of published data assigning MIR6860 a specific regulatory role, disease relevance, or therapeutic interest. - Not a known drug or therapy target: No drugs, mechanism of action, or biomarker data are currently available. - Not misspelled: The name, gene ID, and aliases are correct and consistent across gene annotation resources, but this gene is minimally characterized. If further information is published in the future (e.g., published targets, validated biological roles, disease associations, or drug interactions), these fields can be updated accordingly. Currently, MIR6860 is best classified as a predicted human microRNA gene of unknown function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6860 (MIR6860).